2009
DOI: 10.1111/j.1365-2036.2008.03880.x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient‐guided pharmacological therapy

Abstract: SUMMARY BackgroundHepatic venous pressure gradient (HVPG) monitoring of therapy to prevent variceal rebleeding provides strong prognostic information. Treatment of nonresponders to b-blockers AE nitrates has not been clarified.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
54
0
2

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(56 citation statements)
references
References 35 publications
0
54
0
2
Order By: Relevance
“…Such as the addition of ISMN to b-blockers which enhances the fall in portal pressure achieved using only b-blockers and this combined therapy has shown efficacy in preventing variceal rebleeding. Responders to b-blockers have no further decrease in HVPG with the addition of vasodilators and the beneficial effects are restricted to nonresponders [55,56] . Villaneuva et al [55] carried out a study on cirrhotic patients following a variceal bleed to assess the value of HVPG-guided therapy using nadolol + prazosin in nonresponders to nadolol + ISMN compared with a control group treated with nadolol + ligation.…”
Section: Hvpg Monitoring In Secondary Prophylaxismentioning
confidence: 99%
“…Such as the addition of ISMN to b-blockers which enhances the fall in portal pressure achieved using only b-blockers and this combined therapy has shown efficacy in preventing variceal rebleeding. Responders to b-blockers have no further decrease in HVPG with the addition of vasodilators and the beneficial effects are restricted to nonresponders [55,56] . Villaneuva et al [55] carried out a study on cirrhotic patients following a variceal bleed to assess the value of HVPG-guided therapy using nadolol + prazosin in nonresponders to nadolol + ISMN compared with a control group treated with nadolol + ligation.…”
Section: Hvpg Monitoring In Secondary Prophylaxismentioning
confidence: 99%
“…In patients with intolerance or contraindications to NSBB, EBL is recommended. In subjects without an hemodynamic response to NSBB, there is no consensus on the efficacy of EBL (26,157) .…”
Section: Recommendationsmentioning
confidence: 99%
“…HVPG plays a central role not only in diagnosis, but also for treatment monitoring of portal hypertension (8)(9)(10)(11)(12). Unfortunately, measurement of HVPG is invasive, typically performed by placement of a balloon catheter in the right hepatic vein, via the internal jugular vein, where the difference between the wedged venous pressure and systemic venous pressure is used to estimate HVPG (13)(14)(15)(16).…”
Section: Introductionmentioning
confidence: 99%